Validation of a new homogeneous immunoassay for the detection of carisoprodol in urine

Journal of Analytical Toxicology

Volumn 35, Issue 2, 2011, Pages 108-112

  Wang, Guohong ^a   Huynh, Kim ^a   Barhate, Rekha ^a   Rodrigues, Warren ^a   Moore, Christine ^a   Coulter, Cynthia ^a   Vincent, Michael ^a   Soares, James ^a  

^a Immunalysis Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CARISOPRODOL; MEPROBAMATE;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG URINE LEVEL; ENZYME IMMUNOASSAY; HOMOGENEOUS ENZYME IMMUNOASSAY; HUMAN; LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 79954576640     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/anatox/35.2.108     Document Type: Article

References (13)

1. J.K. Elenbaas. Centrally acting oral skeletal muscle relaxants. Am. J. Hosp. Pharm. 37: 1313-1323 (1980)
2. J. Denisson, J.N. Edwards, and G.N. Volans. Meprobamate over-dosage. Hum. Toxicol. 4: 215-218 (1985).
3. N.C. Elder. Abuse of skeletal muscle relaxants. Am. Fam. Physician 44: 1223-1226 (1991).
4. M. Robertson and L. Marinetti. Carisoprodol-effects on human performance and behavior. Forensic Sci. Rev. 15: 1-9 (2003).
5. L.J. Farrell, S. Kerrigan, and B.K. Logan. Recommendations for tox-icological investigation of drugs impaired driving. J. Forensic Sci. 52(5): 1214-1218 (2007).
6. E.J. Cone, Y.H. Caplan, D.L. Black, T. Robert, and F. Moser. Urine drug testing of chronic pain patients: licit and illicit drug patterns. J. Anal. Toxicol. 32: 530-543 (2008).
7. Carisoprodol ELISA Product Insert. Immunalysis Corporation. Pomona, CA.
8. ®) in bovine serum by liquid chromatography-mass spectrometry. J. Anal. Toxicol. 27: 275-283 (2003).
9. T. Matsumoto, T. Sano, T. Matsuoka, M. Aoki, Y. Maeno, and M. Nagao. Simultaneous determination of carisoprodol and ac-etaminophen in an attempted suicide by liquid chromatography- mass spectrometry with positive electrospray ionization. J. Anal. Toxicol. 27: 118-122 (2003).
10. S. Daval, D. Richard, B. Souweine, A. Eschalier, and F. Coudore. A one-step and sensitive GC-MS assay for meprobamate deter-mination in emergency situations. J. Anal. Toxicol. 30: 302-305 (2006).
11. W. Skinner, D. McKemie, and S. Stanley. Quantitative determi-nation of carisoprodol and its metabolites in equine urine and serum by liquid chromatography-tandem mass spectrometry. Chromatographia 59(Suppl. 1): S61-S67 (2004).
12. D. Downey, K. Simons, K. Ota, and S. Kerrigan. Quantitative analysis of carisoprodol and meprobamate in whole blood using benzylcarbamate and deurerated meprobamate as internal standards. J. Anal. Toxicol. 33: 278-282 (2009).
13. G. Anderson and M. Scott. Determination of product shelf life and activation energy for five drugs of abuse. Clin. Chem. 37: 398-402 (1991).